The Transformative Impact of the African Cohort Study (AFRICOS) Toward Reaching HIV 95-95-95 Goals in Sub-Saharan Africa

the AFRICOS Study Group

doi:10.4269/ajtmh.24-0249

The Transformative Impact of the African Cohort Study (AFRICOS) Toward Reaching HIV 95-95-95 Goals in Sub-Saharan Africa

the AFRICOS Study Group

Research output: Contribution to journal › Review article › peer-review

Abstract

Over the last 20 years, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has rapidly expanded and made remarkable progress toward the UNAIDS 95-95-95 targets to end the HIV epidemic. Nevertheless, HIV continues to pose a significant health challenge globally, with a particular impact on the African continent. Funded by PEPFAR, the African Cohort Study (AFRICOS) has served as a monitoring and evaluation tool for PEPFAR to help guide HIV policy and PEPFAR programming for the last 10 years since its inception and offers a compelling example of how PEPFAR’s investment in science continues to reap dividends. This paper details and critically reviews the transformative research AFRICOS has had on helping to end the HIV epidemic as a public health threat by 2030.

Original language	English
Pages (from-to)	45-55
Number of pages	11
Journal	American Journal of Tropical Medicine and Hygiene
Volume	112
Issue number	1
DOIs	https://doi.org/10.4269/ajtmh.24-0249
State	Published - Jan 2025
Externally published	Yes

Access to Document

10.4269/ajtmh.24-0249

Cite this

@article{4412146fe7b64c51b003862636af35c5,

title = "The Transformative Impact of the African Cohort Study (AFRICOS) Toward Reaching HIV 95-95-95 Goals in Sub-Saharan Africa",

abstract = "Over the last 20 years, the U.S. President{\textquoteright}s Emergency Plan for AIDS Relief (PEPFAR) has rapidly expanded and made remarkable progress toward the UNAIDS 95-95-95 targets to end the HIV epidemic. Nevertheless, HIV continues to pose a significant health challenge globally, with a particular impact on the African continent. Funded by PEPFAR, the African Cohort Study (AFRICOS) has served as a monitoring and evaluation tool for PEPFAR to help guide HIV policy and PEPFAR programming for the last 10 years since its inception and offers a compelling example of how PEPFAR{\textquoteright}s investment in science continues to reap dividends. This paper details and critically reviews the transformative research AFRICOS has had on helping to end the HIV epidemic as a public health threat by 2030.",

author = "{the AFRICOS Study Group} and Neha Shah and Crowell, {Trevor A.} and Jaclyn Hern and Victor Anyebe and Emmanuel Bahemana and Hannah Kibuuka and Valentine Singoei and Jonah Maswai and Ajay Parikh and Duff, {Emma R.} and Cavanaugh, {Joseph Sean} and Romo, {Matthew L.} and Ake, {Julie A.} and Reid, {Michael J.A.} and Nkengasong, {John A.M.B.N.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 The author(s)",

year = "2025",

month = jan,

doi = "10.4269/ajtmh.24-0249",

language = "English",

volume = "112",

pages = "45--55",

journal = "American Journal of Tropical Medicine and Hygiene",

issn = "0002-9637",

number = "1",

}

TY - JOUR

T1 - The Transformative Impact of the African Cohort Study (AFRICOS) Toward Reaching HIV 95-95-95 Goals in Sub-Saharan Africa

AU - the AFRICOS Study Group

AU - Shah, Neha

AU - Crowell, Trevor A.

AU - Hern, Jaclyn

AU - Anyebe, Victor

AU - Bahemana, Emmanuel

AU - Kibuuka, Hannah

AU - Singoei, Valentine

AU - Maswai, Jonah

AU - Parikh, Ajay

AU - Duff, Emma R.

AU - Cavanaugh, Joseph Sean

AU - Romo, Matthew L.

AU - Ake, Julie A.

AU - Reid, Michael J.A.

AU - Nkengasong, John A.M.B.N.

PY - 2025/1

Y1 - 2025/1

N2 - Over the last 20 years, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has rapidly expanded and made remarkable progress toward the UNAIDS 95-95-95 targets to end the HIV epidemic. Nevertheless, HIV continues to pose a significant health challenge globally, with a particular impact on the African continent. Funded by PEPFAR, the African Cohort Study (AFRICOS) has served as a monitoring and evaluation tool for PEPFAR to help guide HIV policy and PEPFAR programming for the last 10 years since its inception and offers a compelling example of how PEPFAR’s investment in science continues to reap dividends. This paper details and critically reviews the transformative research AFRICOS has had on helping to end the HIV epidemic as a public health threat by 2030.

AB - Over the last 20 years, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has rapidly expanded and made remarkable progress toward the UNAIDS 95-95-95 targets to end the HIV epidemic. Nevertheless, HIV continues to pose a significant health challenge globally, with a particular impact on the African continent. Funded by PEPFAR, the African Cohort Study (AFRICOS) has served as a monitoring and evaluation tool for PEPFAR to help guide HIV policy and PEPFAR programming for the last 10 years since its inception and offers a compelling example of how PEPFAR’s investment in science continues to reap dividends. This paper details and critically reviews the transformative research AFRICOS has had on helping to end the HIV epidemic as a public health threat by 2030.

UR - http://www.scopus.com/inward/record.url?scp=85215145836&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.24-0249

DO - 10.4269/ajtmh.24-0249

M3 - Review article

C2 - 39471521

AN - SCOPUS:85215145836

SN - 0002-9637

VL - 112

SP - 45

EP - 55

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

IS - 1

ER -